Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1979-1-26
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0009-9236
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
24
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
714-9
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:710029-Acetylation,
pubmed-meshheading:710029-Adult,
pubmed-meshheading:710029-Drug Interactions,
pubmed-meshheading:710029-Female,
pubmed-meshheading:710029-Humans,
pubmed-meshheading:710029-Hydralazine,
pubmed-meshheading:710029-Male,
pubmed-meshheading:710029-Phenotype,
pubmed-meshheading:710029-Procainamide,
pubmed-meshheading:710029-Time Factors
|
| pubmed:year |
1978
|
| pubmed:articleTitle |
Plasma levels of free and acid-labile hydralazine: effects of multiple dosing and of procainamide.
|
| pubmed:publicationType |
Journal Article
|